Cargando…

Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic form of familial small vessel disease; no preventive or curative therapy is available. CADASIL is caused by mutations in the NOTCH3 gene, resulting in a mutated NOTCH3 re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira, Daniel V, Coupland, Kirsten G, Shao, Wenchao, Jin, Shaobo, Del Gaudio, Francesca, Wang, Sailan, Fox, Rhys, Rutten, Julie W, Sandin, Johan, Zetterberg, Henrik, Lundkvist, Johan, Lesnik Oberstein, Saskia AJ, Lendahl, Urban, Karlström, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906330/ https://www.ncbi.nlm.nih.gov/pubmed/36524456 http://dx.doi.org/10.15252/emmm.202216556

Ejemplares similares

Cognition, mood and behavior in CADASIL
por: Chabriat, Hugues, et al.
Publicado: (2022)

Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL
por: Rutten, Julie W., et al.
Publicado: (2016)

Effect of NOTCH3 EGFr Group, Sex, and Cardiovascular Risk Factors on CADASIL Clinical and Neuroimaging Outcomes
por: Hack, Remco J., et al.
Publicado: (2022)

NO TCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculature
por: Gravesteijn, Gido, et al.
Publicado: (2021)

Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank: CADASIL to nonpenetrance
por: Rutten, Julie W., et al.
Publicado: (2020)

The infantile myofibromatosis NOTCH3 L1519P mutation leads to hyperactivated ligand-independent Notch signaling and increased PDGFRB expression
por: Wu, Dan, et al.
Publicado: (2021)

Commentary to: Masoli et al. Clinical Outcomes of CADASIL-Associated NOTCH3 mutations in 451,424 European Ancestry Community Volunteers. (Translational Stroke Research Oct 2018)
por: Rutten, J. W., et al.
Publicado: (2018)

Naturally occurring NOTCH3 exon skipping attenuates NOTCH3 protein aggregation and disease severity in CADASIL patients
por: Gravesteijn, Gido, et al.
Publicado: (2020)

Eighteen-Year Disease Progression and Survival in CADASIL
por: Gravesteijn, Gido, et al.
Publicado: (2021)

Serum Neurofilament light correlates with CADASIL disease severity and survival
por: Gravesteijn, Gido, et al.
Publicado: (2018)

The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1–6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7–34 pathogenic variant
por: Rutten, Julie W., et al.
Publicado: (2018)

Correction: The effect of NOTCH3 pathogenic variant position on CADASIL disease severity: NOTCH3 EGFr 1–6 pathogenic variant are associated with a more severe phenotype and lower survival compared with EGFr 7–34 pathogenic variant
por: Rutten, Julie W., et al.
Publicado: (2018)

The NOTCH3 score: a pre-clinical CADASIL biomarker in a novel human genomic NOTCH3 transgenic mouse model with early progressive vascular NOTCH3 accumulation
por: Rutten, Julie W., et al.
Publicado: (2015)

Molecular Chaperone BRICHOS Inhibits CADASIL-Mutated NOTCH3 Aggregation In Vitro
por: Oliveira, Daniel V., et al.
Publicado: (2022)

Notch signalling in healthy and diseased vasculature
por: Del Gaudio, Francesca, et al.
Publicado: (2022)

Novel Cysteine-Sparing Hypomorphic NOTCH3 A1604T Mutation Observed in a Family With Migraine and White Matter Lesions
por: Arnardottir, Snjolaug, et al.
Publicado: (2021)

Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population
por: Hack, Remco J., et al.
Publicado: (2020)

Notch signaling promotes a HIF2α-driven hypoxic response in multiple tumor cell types
por: Mutvei, Anders P., et al.
Publicado: (2018)

Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Family Members With a Pathogenic NOTCH3 Variant Can Have a Normal Brain Magnetic Resonance Imaging and Skin Biopsy Beyond Age 50 Years
por: Hack, Remco J., et al.
Publicado: (2022)

NOTCH3 Variants in Patients with Suspected CADASIL
por: Gorukmez, Orhan, et al.
Publicado: (2023)

Broadening the Genetic Horizons of CADASIL: New Variants of the NOTCH3 Gene Revealed and their Association with CADASIL
por: Mishra, Biswamohan, et al.
Publicado: (2023)

Headache and NOTCH3 Gene Variants in Patients with CADASIL
por: Szymanowicz, Oliwia, et al.
Publicado: (2023)

Novel mutation of the notch3 gene in arabic family with CADASIL
por: Bohlega, Saeed
Publicado: (2011)

Biochemical Characterization and Cellular Effects of CADASIL Mutants of NOTCH3
por: Meng, He, et al.
Publicado: (2012)

NOTCH3 and CADASIL syndrome: a genetic and structural overview
por: Papakonstantinou, Eleni, et al.
Publicado: (2019)

Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease prediction
por: Hack, Remco J, et al.
Publicado: (2022)

Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients
por: Tikka, Saara, et al.
Publicado: (2009)

Identification of a Known Mutation in Notch 3 in Familiar CADASIL in China
por: Tan, Zhen-Xuan, et al.
Publicado: (2012)

Notch3 and its CADASIL mutants differentially regulate cellular phenotypes
por: Lin, Chunjing, et al.
Publicado: (2021)

NOTCH3 Variants and Genotype-Phenotype Features in Chinese CADASIL Patients
por: Hu, Yacen, et al.
Publicado: (2021)

A heterozygous mutation in NOTCH3 in a Chinese family with CADASIL
por: Li, Juyi, et al.
Publicado: (2022)

Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease
por: Nordvall, Gunnar, et al.
Publicado: (2023)

Frequency and distribution of Notch mutations in tumor cell lines
por: Mutvei, Anders Peter, et al.
Publicado: (2015)

No vessel wall abnormalities in a human foetus with a NOTCH3 mutation
por: Lesnik Oberstein, Saskia A. J., et al.
Publicado: (2008)

Genetic spectrum of NOTCH3 and clinical phenotype of CADASIL patients in different populations
por: Ni, Wang, et al.
Publicado: (2022)

Corrigendum: A heterozygous mutation in NOTCH3 in a Chinese family with CADASIL
por: Li, Juyi, et al.
Publicado: (2023)

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects
por: Di Donato, Ilaria, et al.
Publicado: (2017)

Combined deficiency of Notch1 and Notch3 causes pericyte dysfunction, models CADASIL, and results in arteriovenous malformations
por: Kofler, Natalie M., et al.
Publicado: (2015)

Differences in proliferation rate between CADASIL and control vascular smooth muscle cells are related to increased TGFβ expression
por: Panahi, Mahmod, et al.
Publicado: (2018)

Notch and Wnt Dysregulation and Its Relevance for Breast Cancer and Tumor Initiation
por: Braune, Eike-Benjamin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fq0ij4e8hsdbf1p2aclu9vmbrr